Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis

Charlotte Hedin(Karolinska University Hospital), Annika Bergquist(Karolinska University Hospital), Aldo J. Montaño‐Loza(University of Alberta), Kristin Kaasen Jørgensen(University of Oslo), Séverine Vermeire(KU Leuven), Nicholas Fonseca Nogueira(University of Miami), Kate D. Lynch(Royal Adelaide Hospital), Bjørn Moum(University of Oslo), Fredrik Rorsman(Uppsala University Hospital), Emma Nilsson(Skåne University Hospital), Christoph Schramm(European Association for the Study of Diabetes), Christopher L. Bowlus(University of California, Davis), Henriette Ytting(University of Copenhagen), Roger W. Chapman, Neta Gotlieb, Ellina Lytvyak(University of Alberta), Oren Shibolet(Tel Aviv University), Alessio Gerussi, Alessandra Zago(University of Padua), Geir Larsson(Oslo University Hospital), Mette Vesterhus(Deaconess Hospital), Cyriel Y. Ponsioen(Amsterdam UMC Location University of Amsterdam), Olivier Chazouillères(Inserm), Christian Rupp(Heidelberg University), Cynthia Levy(University of Miami), Sven Almér(Karolinska University Hospital), Nora Cazzagon(King's College Hospital), Andrew L. Mason(Ochsner Medical Center), Nelson Ndegwa(European Bioinformatics Institute), João Sabino(KU Leuven), Hanns–Ulrich Marschall(University of Padua), Francesca Saffioti(The Royal Free Hospital), Kim N. van Munster(Amsterdam UMC Location University of Amsterdam), Douglas Thorburn(Royal Free London NHS Foundation Trust), Karima Ben Belkacem(Sorbonne Université), Gina Sado(Karolinska University Hospital)
Clinical Gastroenterology and Hepatology
February 14, 2020
Cited by 51


Related Papers